A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection - Kline, M W; Blanchard, S; Fletcher, C V (AIDS Clinical Trials Group 330 Team. Pediatrics, 1999)
et al.